Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2006

01-07-2006 | Epidemiology

Presence of Epithelial Cells in Nipple Aspirate Fluid is Associated with Subsequent Breast Cancer: a 25-Year Prospective Study

Authors: Gertrude Case Buehring, Amy Letscher, Kathleen M. McGirr, Shruti Khandhar, Lisa H. Che, Christine T. Nguyen, Adeline J. Hackett

Published in: Breast Cancer Research and Treatment | Issue 1/2006

Login to get access
Metadata
Title
Presence of Epithelial Cells in Nipple Aspirate Fluid is Associated with Subsequent Breast Cancer: a 25-Year Prospective Study
Authors
Gertrude Case Buehring
Amy Letscher
Kathleen M. McGirr
Shruti Khandhar
Lisa H. Che
Christine T. Nguyen
Adeline J. Hackett
Publication date
01-07-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-005-9132-5

Other articles of this Issue 1/2006

Breast Cancer Research and Treatment 1/2006 Go to the issue

OriginalPaper

Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine★

Preclinical study

Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype

Epidemiology

Association between the apolipoprotein E genotypes and breast cancer patients in Taiwanese

Preclinical study

Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas

Preclinical study

COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic fmolecular markers

Preclinical study

Pathology of borderline HER-2/neu breast carcinoma: a biologically distinct phenotype
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits